Biotech & Health
AI Blood Tests Are Opening a New Front in Early Cancer Detection
AI-powered blood tests from companies like GRAIL, Guardant Health and Freenome are exploring new ways to detect cancer signals through molecular data.
3 articles
AI-powered blood tests from companies like GRAIL, Guardant Health and Freenome are exploring new ways to detect cancer signals through molecular data.
Moderna and Merck say their personalised mRNA cancer therapy met key Phase 3 goals in melanoma, reducing the risk of recurrence and distant metastasis.
Triomics has raised $22 million in Series B funding to scale its oncology-focused AI platform that helps cancer centres streamline clinical workflows, patient data management, and trial…
Written by the reporters who cover each beat. Unsubscribe in one click.